Endocannabinoids Demonstrate Efficacy in Lupus Model
November 01, 2018 09:45 ET
|
Zylö Therapeutics
Zylö’s Nanopod™ Delivery Technology Plays Key Role GREENVILLE, SC, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Zylö Therapeutics, a life science innovator bringing affordable first-to-market therapies to...
CURE Pharmaceutical to Present at CannX 2018 International Medical Cannabis Conference
October 10, 2018 07:25 ET
|
CURE Pharmaceutical
OXNARD, Calif., Oct. 10, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, will be presenting at this year's CannX Conference on October...
Cure Pharmaceutical Plans to Acquire Cannabinoid-Based Drug Pipeline from Therapix Biosciences Ltd.
July 11, 2018 08:57 ET
|
CURE Pharmaceutical
OXNARD, Calif., July 11, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), an innovative drug delivery and development company, announced today that it has signed a term sheet...
CURE Pharmaceutical Attracts Strategic Investment to Speed Its Cannabinoid Drug Delivery Production
May 01, 2018 08:57 ET
|
CURE Pharmaceutical
OXNARD, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced it received an investment of $500,000 from a...